MARKERS OF COAGULATION FIBRINOLYSIS ACTIVATION, AND WHOLE-BLOOD VISCOSITY (WBV) IN PATIENTS UNDERGOING CARDIAC-SURGERY TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO)/
S. Ziemer et al., MARKERS OF COAGULATION FIBRINOLYSIS ACTIVATION, AND WHOLE-BLOOD VISCOSITY (WBV) IN PATIENTS UNDERGOING CARDIAC-SURGERY TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO)/, Thrombosis and haemostasis, 1997, pp. 2142-2142